Sanofi’s experimental drug for a form of multiple sclerosis delayed the progression of disability by nearly a third, ...

"Those with the highest burden of comorbidity had over a 30% increased risk of having disability worsening," Salter said. "In ...

Women had a lower probability of receiving any disease-modifying treatment (DMT) and were even less likely to get ...

Key biomarkers identified can now predict disability progression in multiple sclerosis, offering potential for more ...

A study presented at ECTRIMS 2024 has identified critical biomarkers that can predict disability worsening in multiple ...

Sanofi has shared data from the phase 3 HERCULES trial that could rescue its multiple sclerosis (MS) drug candidate ...

High-dose cholecalciferol (vitamin D) is safe and can nearly double the time it takes for clinically isolated syndrome to ...

A study has uncovered novel ancestry-specific genetic variants linked to multiple sclerosis (MS), offering new insights that ...

Researchers have identified biomarkers that can predict disease progression in multiple sclerosis, which could lead to the ...

When it comes to living with Multiple Sclerosis, community is everything. That's why one organization is holding a fundraiser ...

A short course of Mavenclad can provide long-term reductions in disease activity and disability progression in highly active ...

MS experts are recommending updates to the 2017 McDonald diagnostic criteria that aim to make diagnosis easier, faster and more accurate.